
A cohort of 1.3 million Israeli children found a small composite signal, but investigators say penicillin allergy delabeling practice should not change.

Eyal Kristal, MD, from the pediatric allergy and immunology clinic at Saban Children's Hospital, Soroka University Medical Center in Israel.